About this trial
In the current study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in improving executive function across neuropsychiatric populations known to have deficits in this cognitive domain.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Male and female outpatients 18-65 years of age
A diagnosis of traumatic brain injury, major depressive disorder, bipolar disorder, schizophrenia, attention deficit hyperactivity disorder, borderline personality disorder and substance use disorders meeting the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria.
Disqualifiers
Contraindication to tDCS: history or epilepsy, metallic implants in the head and neck, brain stimulators, vagus nerve stimulators, shunts, pacemakers, pregnancy.
Active substance dependence (except for tobacco and cannabis).
Pregnant or nursing females.
Inability to participate in testing procedures.
Trial design
Parallel
Treatments tested in this trial
Transcranial Direct Current Stimulation
DeviceIn tDCS, electrodes are applied on the scalp to transmit direct current at low current amplitudes.
Treatment groups
8
Treatment groupsSee each treatment group below.
Trial outcomes
Primary outcomes
Change in N-Back Task
Working Memory Task
Secondary outcomes
Change in Flanker Task
Attention and Inhibitory Control Task
Change in Multi-Source Interference with International Affective Picture System Task
Cognitive Control During Emotional Regulation Task
Change in Delayed Discounting Task
Decision-Making Task
Change in Stop Signal Task
Ability to Inhibit a Response Task
Sponsors and contacts
Click on the lead sponsor to view all of their trials.